← FDA DRUG APPROVALS

FDA ANDA · ANDA207270

MORPHINE SULFATE

Sponsor: DR REDDYS LABS SA

APPLICATION
ANDA207270
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-12
LATEST ACTION
2022-01-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 15MG · TABLET · ORAL
MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 30MG · TABLET · ORAL

Approval history

2022-01-12UNKNOWN · Original · standard — REMS ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →